Recalls / Class I
Class ID-0396-2026
Class I— FDA's most serious classification, issued when there is a reasonable probability that use of or exposure to the drug will cause serious adverse health consequences or death.
Product
Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0
- Affected lot / code info
- ALL LOTS, exp 12/31/2027
Why it was recalled
Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Recalling firm
- Firm
- Mohamed Hagar
- Notification channel
- Type
- Voluntary: Firm initiated
- Address
- 4952 Highway 169 N, N/A, Brooklyn Ctr, Minnesota 55428-4026
Distribution
- Quantity
- 125 boxes
- Distribution pattern
- U.S. Nationwide
Timeline
- Recall initiated
- 2025-10-08
- FDA classified
- 2026-03-17
- Posted by FDA
- 2026-03-11
- Status
- Ongoing
Source: openFDA Drug Enforcement endpoint. Recall record D-0396-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.